http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019154441-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb1b6adaa54ee51c854d8d83be5bca09 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 |
filingDate | 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e85567ada2a2d5da3e83716dbeca94e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beb217a7ab20ce8e4e446a218fea2cac |
publicationDate | 2019-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019154441-A |
titleOfInvention | Multiple pH buffer formulation and buffer composition of protein hydrolysis efficiency enhancer for both pepsin and trypsin and uses thereof |
abstract | Provided is a multiple pH value buffer formulation that functions optimally under different pH conditions in the gastrointestinal tract to enhance the proteolytic and absorption efficiency of human pepsin and trypsin. The use of a buffer composition for preparing an enhancer to improve the proteolytic efficiency of pepsin and trypsin in the human body, the buffer composition comprising an acid component that is citric acid, and citric acid A salt component that is a salt, and a protein hydrolysis efficiency enhancer for both pepsin and trypsin that is one selected from the group consisting of ascorbic acid, a salt of ascorbic acid, and combinations thereof, the acid component and The salt components are conjugated to each other to form a buffer formulation, which stabilizes the activity of the proteolytic efficiency enhancer for both pepsin and trypsin at a pH of 5 to 7.5, in the human body. Use of a buffer composition characterized by improving the proteolytic efficiency of pepsin and trypsin. [Selection] Figure 1 |
priorityDate | 2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.